4.5 Article

The Importance of Reference Gene Analysis of Formalin-Fixed, Paraffin-Embedded Samples from Sarcoma Patients - An Often Underestimated Problem

Journal

TRANSLATIONAL ONCOLOGY
Volume 7, Issue 6, Pages 687-693

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.tranon.2014.09.012

Keywords

-

Categories

Funding

  1. A. P. Moller and Christine McKinney Moller Foundation

Ask authors/readers for more resources

Objective: Reverse transcription quantitative real-time polymerase chain reaction is efficient for quantification of gene expression, but the choice of reference genes is of paramount importance as it is essential for correct interpretation of data. This is complicated by the fact that the materials often available are routinely collected formalin-fixed, paraffin-embedded (FFPE) samples in which the mRNA is known to be highly degraded. The purpose of this study was to investigate 22 potential reference genes in sarcoma FFPE samples and to study the variation in expression level within different samples taken from the same tumor and between different histologic types. Methods: Twenty-nine patients treated for sarcoma were enrolled. The samples encompassed 82 (FFPE) specimens. Extraction of total RNA from 7-mu m FFPE sections was performed using a fully automated, bead-base RNA isolation procedure, and 22 potential reference genes were analyzed by reverse transcription quantitative real-time polymerase chain reaction. The stability of the genes was analyzed by RealTime Statminer. The intrasamples variation and the interclass correlation coefficients were calculated. The linear regression model was used to calculate the degradation of the mRNA over time. Results: The quality of RNA was sufficient for analysis in 84% of the samples. Recommended reference genes differed with histologic types. However, PPIA, SF3A1, and MRPL19 were stably expressed regardless of the histologic type included. The variation in Cq value for samples from the same patients was similar to the variation between patients. It was possible to compensate for the time-dependent degradation of the mRNA when normalization was made using the selected reference genes. Conclusion: PPIA, SF3A1, and MRPL19 are suitable reference genes for normalization in gene expression studies of FFPE samples from sarcoma regardless of the histology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

Time structure of pencil beam scanning proton FLASH beams measured with scintillator detectors and compared with log files

Eleni Kanouta, Jacob Graversen Johansen, Gustavo Kertzscher, Mateusz Krzysztof Sitarz, Brita Singers Sorensen, Per Rugaard Poulsen

Summary: A fast scintillator detector system was developed to measure the spot and transition duration in FLASH treatments. The detector system was tested in both phantom and in vivo experiments, showing good agreement with log files and demonstrating its feasibility for preclinical studies.

MEDICAL PHYSICS (2022)

Article Genetics & Heredity

Danish heritable retinoblastoma survivors' perspectives on reproductive choices: It's important for me, not to pass on this condition

Pernille A. Gregersen, Mikkel Funding, Jan Alsner, Maja H. Olsen, Jens Overgaard, Steen F. Urbak, Sandra E. Staffieri, Stina Lou

Summary: Survivors of heritable retinoblastoma face complex and difficult reproductive decision-making, with a strong desire to avoid passing on the disease to their children. They consider various medical, practical, emotional, and moral issues in their family planning process, and express feelings of guilt. Healthcare professionals should provide necessary information and tools to support their unique decision-making process.

JOURNAL OF GENETIC COUNSELING (2023)

Article Oncology

Pretreatment Platelet Count is a Prognostic Marker in Lung Cancer: A Danish Registry-based Cohort Study

Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Anne Winther-Larsen

Summary: This study evaluated the prognostic significance of platelet count in lung cancer patients. The results showed that low and high platelet count were significantly correlated with inferior overall survival in non-small-cell lung cancer (NSCLC) patients, while low platelet count was significantly associated with inferior overall survival in small-cell lung cancer (SCLC) patients.

CLINICAL LUNG CANCER (2023)

Article Oncology

Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value

Mette Abildgaard Pedersen, Thomas Baad-Hansen, Lars C. Gormsen, Steen Baerentzen, Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Mikkel Holm Vendelbo

Summary: This study aimed to evaluate the prognostic accuracy of combining PET parameters and circulating biomarkers in sarcoma patients. The results showed that adding PET parameters to existing prognostic models improved the prognostic value in all models. A new prognostic model, SBSpib, which includes albumin, lymphocytes, and metabolic tumor volume (MTV) as PET parameter, was developed. The study suggests that combining PET parameters and circulating biomarkers can enhance prognostic evaluation, but further validation is needed for SBSpib.

CANCERS (2023)

Article Oncology

Local disease control after stereotactic body radiotherapy in patients with neuroendocrine neoplasms: a cohort study

Anneli Dowler Nygaard, Ninna Aggerholm Pedersen, Gitte Aaroe Dam, Marianne Marquard Knap, Elizaveta Mitkina Tabaksblat

Summary: This study suggests that SBRT may be a feasible and effective treatment for neuroendocrine neoplasms in selected cases. SBRT provides long-term local stability and may be useful in treating patients with localized disease not fit for surgery.

ACTA ONCOLOGICA (2023)

Article Public, Environmental & Occupational Health

Effects of light-guided nudges on health care workers' hand hygiene behavior

Anne-Mette Iversen, Marco Bo Hansen, Jan Alsner, Brian Kristensen, Svend Ellermann-Eriksen

Summary: Nudging with sensor lights can improve and sustain the hand hygiene compliance of physicians and nurses, reducing hospital-acquired infections.

AMERICAN JOURNAL OF INFECTION CONTROL (2023)

Article Oncology

Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel

Judit Kisistok, Ditte Sigaard Christensen, Mads Heilskov Rasmussen, Lone Duval, Ninna Aggerholm-Pedersen, Adam Andrzej Luczak, Boe Sandahl Sorensen, Martin Roelsgaard Jakobsen, Trine Heide Oellegaard, Nicolai Juul Birkbak

Summary: Immunotherapy has dramatically improved the treatment outcomes for metastatic melanoma patients, but it also brings immune-related adverse events. Identifying nonresponding patients early is crucial, and this study explores the use of circulating tumor DNA (ctDNA) analysis as a minimally invasive tool. In a cohort of 24 melanoma patients, the presence of ctDNA was associated with poor prognosis, suggesting its potential to be used in clinical practice.

MELANOMA RESEARCH (2023)

Article Oncology

Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: A DBCG study based on modern radiation therapy techniques

Marie Louise Holm Milo, Ditte Slot Moller, Tine Bisballe Nyeng, Lone Hoffmann, Henrik Dahl Nissen, Ingelise Jensen, Ebbe Laugaard Lorenzen, Lise Bech Jellesmark Thorsen, Kirsten Melgaard Nielsen, Soren Paaske Johnsen, Jan Brink Valentin, Jan Alsner, Birgitte Vrou Offersen

Summary: This study aimed to report the radiation therapy (RT) doses to the heart and cardiac substructures in breast cancer patients treated with CT-based RT and investigate the potential dose-response relationship between RT dose and coronary artery disease (CAD). The results showed that CAD tended to occur in the part of the heart with the highest left-minus-right dose difference, but no significant risk of CAD was observed at a median follow-up of 7 years.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Oncology

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients

Ninna Aggerholm-Pedersen, Henriette Nymark Friis, Thomas Baad-Hansen, Holger Jon Moller, Birgitte Sandfeld-Paulsen

Summary: About 40 percent of patients with primary sarcoma experience relapse after treatment, leading to a low survival rate. Previous studies have failed to improve survival through adjuvant chemotherapy. This study provides a prognostic profile for sarcoma patients, identifying those who may not require additional treatment and those who would benefit from adjuvant treatment. The study also highlights the importance of the innate immune system in the prognosis of sarcoma patients.

CANCERS (2023)

Review Health Care Sciences & Services

Targeted Treatment of Soft-Tissue Sarcoma

Anne Iren Riskjell, Vivi-Nelli Makinen, Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen

Summary: This study provides an overview of the clinical experiences with targeted treatments in patients with soft-tissue sarcoma (STS). MDM2 inhibitors were the most commonly studied drug, with promising results. However, more evidence is needed to determine the efficacy of other targeted agents for specific genetic alterations in STS.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Oncology

An experimental setup for proton irradiation of a murine leg model for radiobiological studies

Cathrine Bang Overgaard, Fardous Reaz, Mateusz Sitarz, Per Poulsen, Jens Overgaard, Niels Bassler, Cai Grau, Brita Singers Sorensen

Summary: This study introduced an experimental radiobiological setup for in vivo irradiation of a mouse leg target along a proton beam path. The setup was used to investigate normal tissue and tumor models with varying linear energy transfer. The results showed that acute skin damage was reversible, while radiation-induced late damage was irreversible.

ACTA ONCOLOGICA (2023)

Article Oncology

Role of high-sensitivity C-reactive protein in patients with sarcoma

Ninna Aggerholm-Pedersen, Thomas Baad-Hansen, Holger Jon Moller, Birgitte Sandfeld-Paulsen

Summary: This study investigated the prognostic value of high-sensitivity C-reactive protein (hs-CRP) in patients with sarcoma and found that elevated levels of hs-CRP were associated with increased overall mortality and decreased progression-free survival.

ONCOLOGY LETTERS (2023)

Article Oncology

Proton therapy planning and image-guidance strategies within a randomized controlled trial for high-risk prostate cancer

Sofie Tilbaek, Ludvig Paul Muren, Anne Vestergaard, Liliana Stolarczyk, Heidi S. Ronde, Tanja S. Johansen, Jimmi Sondergaard, Morten HOyer, Jan Alsner, Lise Norgaard Bentzen, Stine Elleberg Petersen

Summary: The Danish Prostate Cancer Group is conducting a randomized trial comparing photons and protons for the treatment of high-risk prostate cancer. The aim of this study was to establish a feasible and robust strategy for conventionally fractionated proton therapy of the prostate and pelvic lymph nodes in preparation for this trial. Proton treatments are guided by imaging systems and optimized to minimize range uncertainties and reduce gastrointestinal toxicity.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Elnaz Naderi, Miguel E. Aguado-Barrera, Line M. H. Schack, Leila Dorling, Tim Rattay, Laura Fachal, Holly Summersgill, Laura Martinez-Calvo, Ceilidh Welsh, Tom Dudding, Yasmin Odding, Ana Varela-Pazos, Rajesh Jena, David J. Thomson, Roel J. H. M. Steenbakkers, Joe Dennis, Ramon Lobato-Busto, Jan Alsner, Andy Ness, Chris Nutting, Antonio Gomez-Caamano, Jesper G. Eriksen, Steve J. Thomas, Amy M. Bates, Adam J. Webb, Ananya Choudhury, Barry S. Rosenstein, Begona Taboada-Valladares, Carsten Herskind, David Azria, David P. Dearnaley, Dirk de Ruysscher, Elena Sperk, Emma Hall, Hilary Stobart, Jenny Chang-Claude, Kim De Ruyck, Liv Veldeman, Manuel Altabas, Maria Carmen De Santis, Marie-Pierre Farcy-Jacquet, Marlon R. Veldwijk, Matthew R. Sydes, Matthew Parliament, Nawaid Usmani, Neil G. Burnet, Petra Seibold, R. Paul Symonds, Rebecca M. Elliott, Renee Bultijnck, Sara Gutierrez-Enriquez, Meritxell Molla, Sarah L. Gulliford, Sheryl Green, Tiziana Rancati, Victoria Reyes, Ana Carballo, Paula Peleteiro, Paloma Sosa-Fajardo, Chris Parker, Valerie Fonteyne, Kerstie Johnson, Maarten Lambrecht, Ben Vanneste, Riccardo Valdagni, Alexandra Giraldo, Monica Ramos, Brenda Diergaarde, Geoffrey Liu, Suzanne M. Leal, Melvin L. K. Chua, Miranda Pring, Jens Overgaard, Luis M. Cascallar-Caneda, Frederic Duprez, Christopher J. Talbot, Gillian C. Barnett, Alison M. Dunning, Ana Vega, Christian Nicolaj Andreassen, Johannes A. Langendijk, Catharine M. L. West, Behrooz Z. Alizadeh, Sarah L. Kerns

Summary: This study identified shared genetic susceptibility for acute radiation-induced toxicity across different cancer types, with a shared SNV-based heritability estimated at around 10%. Higher heritability rates were found for prostate, head and neck, and breast cancers. Additionally, several potentially associated SNVs and gene sets related to acute toxicity were discovered.

JNCI CANCER SPECTRUM (2023)

Meeting Abstract Oncology

CD8 positive cells indicate gain of postmastectomy radiotherapy: a study of the DBCG82bc cohort

T. Tramm, P. S. Nielsen, J. B. Georgsen, J. Overgaard, J. Alsner

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods

Xiaofan Pu, Chaolei Zhang, Guoping Ding, Hongpeng Gu, Yang Lv, Tao Shen, Tianshu Pang, Liping Cao, Shengnan Jia

Summary: This study demonstrated the potential utility of the sEV-miRNA d-signature in the diagnosis of PDAC via machine learning methods. A novel sEV biomarker, miR-664a-3p, was identified for the diagnosis of PDAC. It can also potentially promote angiogenesis and metastasis, provide insight into PDAC pathogenesis, and reveal novel regulators of this disease.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Silencing of PD-1 combined with EBV-specific killer T cells for the treatment of EBV-associated B lymphoma

Jiaping Wang, Zhijuan Xu, Yanli Lai, Yanli Zhang, Ping Zhang, Qitian Mu, Shujun Yang, Yongcheng Sun, Lixia Sheng, Guifang Ouyang

Summary: This study demonstrates the significance of PD-1 in EBV-infected lymphoma cells. Silencing PD-1 enhances the tumor targeting effect of EBV-specific killer T cells on B lymphocytes and attenuates the immune escape effect.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer

Qiliang Peng, Jialong Tao, Yingjie Xu, Yi Shen, Yong Wang, Yang Jiao, Yiheng Mao, Yaqun Zhu, Yulong Liu, Ye Tian

Summary: This study investigates the potential role of lipid metabolism-associated genes (LMAGs) in neoadjuvant chemoradiotherapy (nCRT) and immunotherapy for rectal cancer. The results suggest that the SREBF2 gene is a highly predictive factor for nCRT in rectal cancer and is associated with favorable prognosis. SREBF2 is also closely associated with immune cell infiltration and immunotherapy-related genes.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells

Shiquan Li, Nan Zhang, Yongping Yang, Tongjun Liu

Summary: This study investigated the potential molecular mechanism of SPDEF in immune evasion of colorectal cancer (CRC) and found that it suppresses immune evasion by activating CCL28 through the modulation of M2 polarization of macrophages. These findings provide a new research direction and potential therapeutic target for immunotherapy in CRC.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends

Manas Sehgal, Soundharya Ramu, Joel Markus Vaz, Yogheshwer Raja Ganapathy, Srinath Muralidharan, Sankalpa Venkatraghavan, Mohit Kumar Jolly

Summary: This study investigates the relationship between gene expression patterns and phenotypic plasticity and heterogeneity in colorectal cancer (CRC). The results demonstrate the interconnectedness between different Consensus Molecular Subtypes (CMS) of CRC and specific phenotypes such as epithelial and mesenchymal characteristics. Additionally, the study reveals correlations between metabolic pathways and phenotypic scores, as well as between PD-L1 activity and mesenchymal phenotype. Single-cell RNA sequencing analysis further confirms the heterogeneity of different CMS subtypes. These findings have important implications for understanding CRC heterogeneity and developing targeted therapies.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Ceramide metabolism-related prognostic signature and immunosuppressive function of ST3GAL1 in osteosarcoma

Yutong Zou, Siyao Guo, Yan Liao, Weidong Chen, Ziyun Chen, Junkai Chen, Lili Wen, Xianbiao Xie

Summary: This study found that ceramide metabolism is associated with the progression and clinical outcome of osteosarcoma by analyzing data from osteosarcoma patients. The gene ST3GAL1 plays an important role in osteosarcoma, regulating the tumor immune microenvironment and affecting T cell function. It may become a new target for the treatment of osteosarcoma.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

GPR37-centered ceRNA network contributes to metastatic potential in lung adenocarcinoma: Evidence from high-throughput sequencing

Chuanhui Chen, Mengzhi Wan, Xiong Peng, Qing Zhang, Yu Liu

Summary: This study examines the function and mechanism of the ceRNA network centered around GPR37 in LUAD. The findings show that high expression of GPR37 in LUAD tissue samples is associated with poor prognosis, and it may regulate the expression of downstream target genes by competitively binding to lncRNA DLEU1 and miR-4458.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer

Junping Li, Hong Hu, Jinping He, Yuling Hu, Manting Liu, Bihui Cao, Dongni Chen, Xiaodie Ye, Jian Zhang, Zhiru Zhang, Wen Long, Hui Lian, Deji Chen, Likun Chen, Lili Yang, Zhenfeng Zhang

Summary: Sequential administration of CDC7 inhibitor XL413 after carboplatin enhances the chemotherapeutic effect of carboplatin on ovarian cancer cells, possibly by inhibiting homologous recombination repair activity and increasing the accumulation of chemotherapy-induced DNA damage.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Dual role of CASP8AP2/FLASH in regulating epithelial-to-mesenchymal transition plasticity (EMP)

Madison Catalanotto, Joel Markus Vaz, Camille Abshire, Reneau Youngblood, Min Chu, Herbert Levine, Mohit Kumar Jolly, Ana -Maria Dragoi

Summary: The study demonstrates that loss of FLASH in cancer cells leads to a hybrid E/M phenotype with high epithelial scores, suggesting FLASH acts as a repressor of the epithelial phenotype. Additionally, FLASH expression is inversely correlated with the epithelial score and subsets of mesenchymal markers are distinctly up-regulated in FLASH, NPAT, or SLBP-depleted cells.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer

Xiaorui Wang, Na Li, Minying Zheng, Yongjun Yu, Shiwu Zhang

Summary: Adipocytes are derived from pluripotent mesenchymal stem cells and histone modifications play a key role in their differentiation. Recent studies have shown that cancer stem cells can differentiate into adipocytes, reducing the malignancy of cancer cells.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance

Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, Sheema Hashem, Muzafar A. Macha, Ammira S. Al-Shabeeb Akil, Ajaz A. Bhat

Summary: Cancer heterogeneity and drug resistance are major obstacles to effective cancer treatment, and epigenetic modifications play a pivotal role in these processes. This review explores essential epigenetic modifications, including DNA methylation, histone modifications, and chromatin remodeling, and discusses their complex contributions to cancer biology. However, the interplay of epigenetic and genetic changes in cancer cells presents unique challenges that must be addressed to fully exploit the potential of epigenetic modifications.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC

Pedro De Marchi, Leticia Ferro Leal, Luciane Sussuchi da Silva, Rodrigo de Oliveira Cavagna, Flavio Augusto Ferreira da Silva, Vinicius Duval da Silva, Eduardo C. A. da Silva, Augusto O. Saito, Vladmir C. Cordeiro de Lima, Rui Manuel Reis

Summary: The TIS and IFN-gamma signatures are predictive biomarkers for identifying NSCLC patients who could potentially benefit from immune checkpoint inhibitor therapies.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence

Giovanni Marchi, Anna Rajavuori, Mai T. N. Nguyen, Kaisa Huhtinen, Sinikka Oksa, Sakari Hietanen, Sampsa Hautaniemi, Johanna Hynninen, Jaana Oikkonen

Summary: The study shows that ctDNA can adequately represent high-grade serous ovarian carcinoma (HGSC), and the mutations observed at relapse suggest personalized therapy options.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models

Yuncang Yuan, Jiawei Fan, Dandan Liang, Shijie Wang, Xu Luo, Yongjie Zhu, Nan Liu, Tingxiu Xiang, Xudong Zhao

Summary: This study demonstrates that csGRP78-directed CAR-T cells can selectively kill pancreatic cancer cells, and the combination with chemotherapy enhances cytotoxicity.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Bulky glycocalyx shields cancer cells from invasion-associated stresses

Niyati Piplani, Tanusri Roy, Neha Saxena, Shamik Sen

Summary: The glycocalyx, a protective barrier surrounding cells, has been found to play a role in cancer cell proliferation, survival, and metastasis. However, its function in maintaining DNA/nuclear integrity during migration through dense matrices has not been explored. This study shows that the bulkiness of the glycocalyx is inversely associated with nuclear stresses, and highlights its mechanical role in shielding migration-associated stresses.

TRANSLATIONAL ONCOLOGY (2024)